Feng Lin

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. Zhang L, Bell B, Yu M, Chan C, Peachey N, Fung J, et al. Complement anaphylatoxin receptors C3aR and C5aR are required in the pathogenesis of experimental autoimmune uveitis. J Leukoc Biol. 2016;99:447-54 pubmed publisher
  2. Xu J, Zhang L, Xie M, Li Y, Huang P, Saunders T, et al. Role of Complement in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy. J Immunol. 2018;200:4094-4101 pubmed publisher
    ..Our findings demonstrate a previously unknown but pivotal role of complement in CIPN and suggest that complement may be a new target for the development of novel therapeutics to manage this painful disease. ..
  3. Zhang L, Fedorov Y, Adams D, Lin F. Identification of complement inhibitory activities of two chemotherapeutic agents using a high-throughput cell imaging-based screening assay. Mol Immunol. 2018;101:86-91 pubmed publisher
    ..In summary, this work has established a simple, large-scale, high-throughput assay for screening novel complement inhibitors and discovered previously unknown complement activation inhibitory activities for cisplatin and pyridostatin. ..
  4. Han J, Enyindah Asonye G, Lin F, Smith J. CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice. BMC Res Notes. 2018;11:229 pubmed publisher
    ..Thus, loss of CD6 on lymphocytes did not lead to expected reductions in B1a cells and protective IgM levels, and in turn did not alter atherosclerosis in mice. ..
  5. Zhang L, Sorensen M, Kristensen B, Reifenberger G, McIntyre T, Lin F. D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells. Clin Cancer Res. 2018;24:5381-5391 pubmed publisher
    ..b>Conclusions: D 2-HG suppresses the host immune system, potentially promoting immune escape of IDH-mutant tumors. Clin Cancer Res; 24(21); 5381-91. ©2018 AACR. ..
  6. Li Y, Clow F, Fraser J, Lin F. Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis. J Mol Med (Berl). 2018;96:965-974 pubmed publisher
    ..SSL7 functions in the presence of anti-SSL7 antibodies both in vitro and in vivo. • SSL7 has the potential to be developed as a new and economical complement inhibitor for treating complement-mediated hemolysis. ..
  7. Li Y, Lu L, Qian S, Fung J, Lin F. Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death-Ligand 1. J Immunol. 2016;196:1617-25 pubmed publisher
    ..This direct B cell-inhibitory activity of HSCs should contribute to the mechanism by which HSCs maintain the liver's immune homeostasis. ..
  8. Zhang L, Li Y, Qiu W, Bell B, Dvorina N, Baldwin W, et al. Targeting CD6 for the treatment of experimental autoimmune uveitis. J Autoimmun. 2018;90:84-93 pubmed publisher
    ..In addition, the newly developed mouse anti-mouse/human CD6 mAbs could be valuable tools for testing CD6-targeted therapies in other mouse models of human diseases. ..
  9. Li Y, Kim B, Qian S, Letterio J, Fung J, Lu L, et al. Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex. J Immunol. 2015;195:2648-56 pubmed publisher
    ..Our study reveals a new mechanism for HSC-mediated immune regulation and potentially for other conditions, such as liver fibrosis, that involve HSC-secreted TGF-β1. ..

Collaborators

More Information

Publications12

  1. Li Y, Singer N, Whitbred J, Bowen M, Fox D, Lin F. CD6 as a potential target for treating multiple sclerosis. Proc Natl Acad Sci U S A. 2017;114:2687-2692 pubmed publisher
  2. Li Y, Qiu W, Zhang L, Fung J, Lin F. Painting factor H onto mesenchymal stem cells protects the cells from complement- and neutrophil-mediated damage. Biomaterials. 2016;102:209-19 pubmed publisher
    ..MSCs painted with factor H are protected from both MAC- and neutrophil-mediated attack and are significantly more effective in inhibiting antigen-specific T cell responses than the mock-painted MSCs both in vitro and in vivo. ..
  3. Enyindah Asonye G, Li Y, Xin W, Singer N, Gupta N, Fung J, et al. CD6 Receptor Regulates Intestinal Ischemia/Reperfusion-induced Injury by Modulating Natural IgM-producing B1a Cell Self-renewal. J Biol Chem. 2017;292:661-671 pubmed publisher
    ..Our results reveal an unexpected role of CD6 in the pathogenesis of intestinal IR-induced injury by regulating the self-renewal of B1a cells. ..